Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frieman

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Biorxiv : the Preprint Server for Biology|November 30, 2021
Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Communications Biology|August 12, 2022
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19James Logue, Arup R Chakraborty, Robert Johnson, et al.
Nature Communications|August 28, 2020
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patientsS G P Funnell, W E Dowling, C Muñoz-Fontela, et al.
Mbio|October 28, 2010
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signalingXinxia Peng, Lisa Gralinski, Christopher D Armour, et al.
Nature Communications|October 6, 2023
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seqSara Sunshine, Andreas S Puschnik, Joseph M Replogle, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialRaburn M Mallory, Neil Formica, Susan Pfeiffer, et al.
Msystems|November 9, 2016
A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA VirusesLindsey A Moser, Lisbeth Ramirez-Carvajal, Vinita Puri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infectionKristen E Pascal, Christopher M Coleman, Alejandro O Mujica, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko Oskotsky, Ivana MariÄ, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|November 30, 2021
Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Communications Biology|August 12, 2022
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19James Logue, Arup R Chakraborty, Robert Johnson, et al.
Nature Communications|August 28, 2020
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patientsS G P Funnell, W E Dowling, C Muñoz-Fontela, et al.
Mbio|October 28, 2010
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signalingXinxia Peng, Lisa Gralinski, Christopher D Armour, et al.
Nature Communications|October 6, 2023
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seqSara Sunshine, Andreas S Puschnik, Joseph M Replogle, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialRaburn M Mallory, Neil Formica, Susan Pfeiffer, et al.
Msystems|November 9, 2016
A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA VirusesLindsey A Moser, Lisbeth Ramirez-Carvajal, Vinita Puri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infectionKristen E Pascal, Christopher M Coleman, Alejandro O Mujica, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko Oskotsky, Ivana MariÄ, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Pageof 25